ArticleGenetic vaccines and therapy2012
A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan.
Article in Genetic vaccines and therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.
- Epidemiological trends and risk factors associated with dengue disease in Pakistan (1980-2014): a systematic literature search and analysis.BMC public health · 2018Pooled it
- Article
- Review
- The impact of dengue viruses: Surveillance, response, and public health implications in Queensland, Australia.Public health in practice (Oxford, England) · 2024Review
- Prediction of virus-host interactions and identification of hot spot residues of DENV-2 and SH3 domain interactions.Archives of microbiology · 2024Article
- Review
- WebGIS-Based Real-Time Surveillance and Response System for Vector-Borne Infectious Diseases.International journal of environmental research and public health · 2023Article
- Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections:Frontiers in cellular and infection microbiology · 2023Review
- A Privacy-Preserved Internet-of-Medical-Things Scheme for Eradication and Control of Dengue Using UAV.Micromachines · 2022Article
- The Future ofMolecules (Basel, Switzerland) · 2021Review
- Prevalence of Larval Breeding Sites and Seasonal Variations ofInternational journal of environmental research and public health · 2021Article
- Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics.Veterinary research · 2021Review
- Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.Scientific reports · 2019Article
- Dengue in Araraquara, state of São Paulo: epidemiology, climate and Aedes aegypti infestation.Revista de saude publica · 2018Article
- Applications of gold nanoparticles in virus detection.Theranostics · 2018Review
- Antiviral activity of Carbenoxolone disodium against dengue virus infection.Journal of medical virology · 2017Article
- Genetic Analysis ofJournal of arthropod-borne diseases · 2016Article
- Water-Related Impacts of Climate Change on Agriculture and Subsequently on Public Health: A Review for Generalists with Particular Reference to Pakistan.International journal of environmental research and public health · 2016Review
- In Silico Screening, Alanine Mutation, and DFT Approaches for Identification of NS2B/NS3 Protease Inhibitors.Biochemistry research international · 2016Article
- A Comprehensive Entomological, Serological and Molecular Study of 2013 Dengue Outbreak of Swat, Khyber Pakhtunkhwa, Pakistan.PloS one · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue virus infection is a serious health problem infecting 2.5 billion people worldwide. Dengue is now endemic in more than 100 countries, including Pakistan. Each year hundreds of people get infected with dengue in Pakistan. Currently, there is no vaccine available for the prevention of Dengue virus infection due to four viral serotypes. Dengue infection can cause death of patients in its most severity, meanwhile many antiviral compounds are being tested against dengue virus infection to eradicate this disease but still there is a need to develop an efficient, low-cost and safe vaccine that can target all the four serotypes of dengue virus. This review summarizes dengue molecular virology, important drug targets, prevalence in Pakistan, diagnosis, treatment and medicinal plant inhibitors against dengue.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.